The role of the microcirculation and integrative cardiovascular physiology in the pathogenesis of ICU-acquired weakness.
Asher A Mendelson, Dustin Erickson, Rodrigo Villar
https://pubmed.ncbi.nlm.nih.gov/37234410Actively Recruiting
Led by University of Manitoba · Updated on 2025-11-28
50
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating how sepsis and critical illness can affect the heart and small blood vessels in patients who have been in the intensive care unit (ICU). This study focuses on understanding how these effects may lead to long-lasting muscle weakness and difficulty exercising, a condition known as ICU-Acquired Weakness (ICU-AW). The research aims to clarify the role of microvascular dysfunction in limiting exercise ability in ICU survivors. The study follows ICU survivors who required mechanical ventilation for at least seven days and have been discharged from the hospital. Participants will undergo assessments at two follow-up points: 6 months and 12 months after ICU discharge. These assessments include cardiopulmonary exercise tests to measure peak oxygen uptake and oxygen kinetics, along with high-resolution near-infrared spectroscopy (NIRS) to evaluate skeletal muscle microvascular function during exercise. During the study, participants will have tests to measure oxygen use and delivery in muscles, cardiovascular blood flow, and physical abilities. Questionnaires and clinical scores will also be used to assess independence, frailty, and muscle strength. Data collection will continue throughout the 12 months, monitoring recruitment and retention. The study aims to gather detailed information on how the cardiovascular system and microcirculation recover or remain impaired after critical illness.
CONDITIONS
ICU Combined Assessment of Cardio-Respiratory Exercise
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 months
Participants are monitored through assessments of cardiovascular fitness and microvascular function at 6 and 12 months after ICU discharge.
Up to 2 visits (in-person) at 6 and 12 months after ICU discharge
Total: 1 location
1
Health Sciences Centre Winnipeg
Winnipeg, Manitoba, Canada, R3A 1R9
Actively Recruiting
A
Asher Mendelson, MD PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Asher A Mendelson, Dustin Erickson, Rodrigo Villar
https://pubmed.ncbi.nlm.nih.gov/37234410Daren K Heyland, Allan Garland, Sean M Bagshaw...
https://pubmed.ncbi.nlm.nih.gov/26306719John Muscedere, Sean M Bagshaw, Gordon Boyd...
https://pubmed.ncbi.nlm.nih.gov/35680740